CPBIO Subsidiary Passes Fifth Consecutive Australian APVMA GMP Audit
2026-07-04 09:00
Author :
From June 2 to 3, 2026, Zhumadian Huazhong Chia Tai Co., Ltd., a subsidiary of CPBIO, successfully completed its fifth consecutive Australian APVMA Veterinary GMP audit with zero major non-conformances, demonstrating its continued commitment to manufacturing quality and regulatory compliance.
This achievement reflects the company's ongoing efforts in intelligent manufacturing, quality traceability, and continuous improvement. By maintaining rigorous quality management standards and strengthening regulatory compliance, CPBIO continues to enhance its manufacturing capabilities and reinforce its position as a reliable supplier of animal health products in international markets.

Previous : CP Poland Delegation Visits CPBIO to Strengthen Strategic Collaboration
Next : CPBIO Welcomes Nutrion Pakistan to Explore Strategic Collaboration
Последние новости